We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Hashish use dysfunction could up threat of benign salivary gland tumors
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Hashish use dysfunction could up threat of benign salivary gland tumors
Hashish use dysfunction could up threat of benign salivary gland tumors
Health

Hashish use dysfunction could up threat of benign salivary gland tumors

Last updated: July 21, 2025 5:36 pm
Editorial Board Published July 21, 2025
Share
SHARE

Hashish use dysfunction (CUD) is related to elevated threat of benign salivary gland tumors, in keeping with a analysis letter revealed on-line July 17 in JAMA Otolaryngology-Head & Neck Surgical procedure.

Tyler J. Gallagher, M.D., M.P.H., from the Keck College of Drugs on the College of Southern California in Los Angeles, and colleagues carried out a retrospective cohort examine utilizing deidentified information from the TriNetX U.S. Collaborative Community to look at the affiliation between hashish use and benign salivary gland tumors. Two cohorts of adults age 18 years or older have been created: one had a analysis of cannabis-related dysfunction and the opposite had no cannabis-related dysfunction analysis between Jan. 24, 2005, and Jan. 24, 2025.

The researchers discovered that the incidence of any benign main salivary gland tumor was larger within the group with CUD (183,818 people) than the group with out CUD (6,248,964 people) (0.08% versus 0.02%). The group with versus with out CUD additionally had larger incidence of benign parotid salivary gland tumors (0.05% versus 0.01%).

After propensity rating matching, the relative threat of any benign main salivary gland tumor was larger amongst these with versus with out CUD in any respect time factors (relative dangers, 5.18, 4.32, and 5.00 at any time, zero to lower than 5 years, and at 5 or extra years, respectively) after CUD analysis or outpatient hospital go to. Elevated relative threat of a benign parotid salivary gland tumor was additionally seen (relative dangers, 5.16, 4.92, and three.90 for any time, zero to lower than 5 years, and 5 or extra years, respectively).

“The elevated relative risk of benign parotid tumors and the persistent association over time highlight potential site-specific outcomes of cannabis use,” the authors write.

Extra data:
Tyler J. Gallagher et al, Hashish Use and Benign Salivary Gland Neoplasms, JAMA Otolaryngology–Head & Neck Surgical procedure (2025). DOI: 10.1001/jamaoto.2025.1955

Quotation:
Hashish use dysfunction could up threat of benign salivary gland tumors (2025, July 21)
retrieved 21 July 2025
from https://medicalxpress.com/information/2025-07-cannabis-disorder-benign-salivary-gland.html

This doc is topic to copyright. Aside from any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.

You Might Also Like

From battlefield to dwelling: How battle fuels household aggression

Human kidney organoids efficiently built-in into pig kidneys in transplant research

FDA restricts use of children’ fluoride dietary supplements citing rising well being dangers

How frequent is sexually abusive conduct between youngsters? How ought to daycare facilities reply?

FDA to ease copycat drug guidelines, rushing entry to cheaper medication

TAGGED:benigncannabisdisorderglandrisksalivaryTumors
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Analysis reveals youngsters’s psychological well being issues happen no matter household revenue stage
Health

Analysis reveals youngsters’s psychological well being issues happen no matter household revenue stage

Editorial Board August 1, 2025
Instagram Faces Investigation Over Mental Health Impact on Teens
Elizabeth Holmes Begins Her Defense in Fraud Trial
Chattanooga vs Louisville: Which Metropolis is Proper for You? Evaluating Actual Property, Value of Residing, Tradition, and Extra
‘Vietnam: The Warfare That Modified America’ examines the human tales of conflict

You Might Also Like

Nature walks are good for you, however can a metropolis stroll be simply pretty much as good?
Health

Nature walks are good for you, however can a metropolis stroll be simply pretty much as good?

November 1, 2025
Radiofrequency renal denervation lowers blood stress in power kidney illness stage 3a, b
Health

Radiofrequency renal denervation lowers blood stress in power kidney illness stage 3a, b

November 1, 2025
Physician tripped up by k invoice for ankle surgical procedure and hospital keep
Health

Physician tripped up by $64k invoice for ankle surgical procedure and hospital keep

November 1, 2025
Measles outbreak in Utah, Arizona grows to over 130 instances
Health

Measles outbreak in Utah, Arizona grows to over 130 instances

November 1, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?